REDWOOD SHORES, CA--(Marketwired - Jun 24, 2013) - Oracle (NASDAQ: ORCL) News Facts To help health sciences organizations meet increasingly stringent regulatory requirements and ensure product safety ...

Oracle (NYSE:ORCL) was in focus on Thursday as investment firm Argus raised its earnings estimates and upgraded the IT tech giant after it reported fiscal third-quarter results. Shares were flat in ...

AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research Organization (CRO), PrimeVigilance, is significantly enhancing its service offerings with Oracle Argus. Delivering the full lifecycle of ...

Argus analyst Joseph Bonner raised the firm’s price target on Oracle (ORCL) to $200 from $176 and keeps a Buy rating on the shares after its Q2 results. The company is in the enviable position of ...

On Thursday, Oracle (NYSE:ORCL) received an upgrade from Argus, moving from a Hold to a Buy rating, accompanied by a new price target set at $145 per share. The upgrade follows Oracle's reported ...

New Oracle Argus and Safety One Intake enhancements make it easier for pharmacovigilance teams to increase efficiency and address global regulatory compliance AUSTIN, Texas – July 10, 2024 – Oracle ...

new and ever-changing pharmacovigilance and safety requirements. Efficient and effective management of these processes is vital from both a safety and business perspective," said Neil de Crescenzo, ...

REDWOOD SHORES, Calif., Feb. 13, 2018 /PRNewswire/ -- Oracle Health Sciences today announced that the latest release of Oracle Argus, the company's safety and pharmacovigilance software, fully ...

Argus, a financial analysis firm, has upgraded its price target for Oracle Corporation (NYSE: NYSE:ORCL) from $159.00 to $176.00 while maintaining a Buy rating on the shares. The firm highlighted ...

To help clinical trial sponsors and contract research organizations (CROs) more cost-effectively and efficiently capture and manage information on adverse events, Oracle has integrated Oracle Health ...

Contract Research Organization aims to improve data management, accuracy, and safety with Oracle's AI-powered pharmacovigilance platform AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research ...